PATENT CLAIM ANALYSIS

Application Number: 16003565
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "130000"]

Abstract:
Benzocyclooctene (fused 6,8 ring system) analogues and corresponding indene (fused 6,5 ring system) analogues function as inhibitors of tubulin polymerization. The compounds are useful as anticancer agents in a new therapeutic approach for cancer treatment utilizing small-molecule inhibitors of tubulin polymerization that also act as vascular disrupting agents (VDAs).

Claim (Index 7):
The method of  claim 6 , wherein the benzocyclooctene compound has a structure of:

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.39024
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13216927', '12981233', '13676650', '15309357', '15858183']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747243808049518
- 35 USC 102 Novelty (BERT): 0.5044674783048574
- Combined Prediction Score: 0.7476986905549423
- Mean Citation Score: 250.81393
- Max Citation Score: 263.24713
- Similarity Product: 194.72043950123668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test